Zobrazeno 1 - 10
of 265
pro vyhledávání: '"Shore, Nd"'
Publikováno v:
Research and Reports in Urology, Vol 2012, Iss default, Pp 49-56 (2012)
Neal D Shore,1 Cecilia A Fernandez,2 Anthony P Shuber21Carolina Urologic Research Center/Atlantic Urology Clinics, Myrtle Beach, SC, 2Predictive Biosciences Inc, Lexington, MA, USABackground: The purpose of this study was to establish the clinical pe
Externí odkaz:
https://doaj.org/article/6645b4ba9fa74cf2bb7f5a5a12605dca
Autor:
Shore, ND, Redorta, JP, Robert, G, Hutson, TE, Cesari, R, Hariharan, S, Faba, G, Briganti, A, Steinberg, GD
Publikováno v:
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Aim: This review article summarizes the current clinical practice guidelines around disease definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer (NMIBC). Recently completed and ongoing clinical trials of novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::56b5320a5a851ddff6d27faa8e026b76
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5393
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5393
Autor:
Ravaud, A, Motzer, Rj, Pandha, Hs, George, Dj, Pantuck, Aj, Patel, A, Chang, Yh, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M1, Lin, X, Martini, Jf, Ramaswamy, K, Casey, M, Staehler, M, Patard, Jj, Gruenwald, V, Link, K, Doehn, C, Heinzer, H, Grimm, M-O, Wirth, M, Stoeckle, M, Heidenreich, A, Garcia del Muro Solans, X, Mellado, Bo, Castellano, Dg, Frydenberg, M, Schobinger, Sr, Dimopoulos, Ma, Rothermundt, C, Climent Duran MA, Melotti, B, Procopio, G, Boccardo, F, Sella, A, Stewart, S, Adenis, A, Jones, Rj, Chevreau, C, Prausova, J, Vyzula, R, Oudard, S, Jacqmin, D, Gravis, G, Varela, R, Herrmann, E, Lim, Hy, Lee, J-L, Kim, Yh, Kim, Jh, Y-C, Ou, Papakotoulas, P, Iacobelli, S, Chowdhury, S, Passalacqua, R, Tomasek, J, Anton Aparicio LM, Linassier, C, Hauser, S, Bergmann, L, Hawkins, Re, Szczylik, C, Zdrojowy, R, Sosnowski, M, Koralewski, P, Wiechnio, Pj, Schraml, J, Mardiak, J, Laurinc, P, Kliment, J, Rosenbaum, E, Lundstam, S, Flodgren, P, Ljungberg, B, Stenzl, A, Schnoeller, Tj, Mcdermott, Sr, Breathnach, Os, Mccaffrey, Ja, Donnellan, P, The, G-C, Rolland, F, Brekkan, E, Nilsson, C, Kim, Wy, Bishoff, J, Chung, J, Shore, Nd, Master, V, Tang Chen DY, Ye, D, Huang, Y, Jin, J, Song, B, Zhou, F, Galceran, Jc, Yao, X, Zhang, X.
Publikováno v:
Ravaud, A, Motzer, R J, Pandha, H S, George, D J, Pantuck, A J, Patel, A, Chang, Y-H, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Gerletti, P, Lechuga, M, Lin, X, Martini, J-F, Ramaswamy, K, Casey, M, Staehler, M, Patard, J-J & S-TRAC Investigators 2016, ' Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy ', The New England Journal of Medicine, vol. 375, no. 23, pp. 2246-2254 . https://doi.org/10.1056/NEJMoa1611406
BACKGROUNDSunitinib, a vascular endothelial growth factor pathway inhibitor, is an effectivetreatment for metastatic renal-cell carcinoma. We sought to determine the efficacyand safety of sunitinib in patients with locoregional renal-cell carcinoma a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044148e0163ba78bfbd9d2be3de578c8
https://surrey.eprints-hosting.org/812586/
https://surrey.eprints-hosting.org/812586/
Autor:
Schröder, Fritz, Tombal, B, Miller, K, Boccon-Gibod, L, Shore, ND, Crawford, ED, Moul, J, Olesen, TK, Persson, BE
Publikováno v:
BJU International, 106(2), 182-187. Wiley-Blackwell Publishing Ltd
OBJECTIVE To compare the activity of degarelix, a new gonadotrophin-releasing hormone (GnRH) blocker, with leuprolide depot 7.5 mg in the control of total serum alkaline phosphatase (S-ALP) levels in patients with prostate cancer. PATIENTS AND METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::484970bba6c4e71248d472c3cd2a0c4b
https://pure.eur.nl/en/publications/b3cf9db8-f25a-4a94-ba37-988d3d455f26
https://pure.eur.nl/en/publications/b3cf9db8-f25a-4a94-ba37-988d3d455f26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Urology Times; 7/1/2009, Vol. 37 Issue 8, p16-19, 4p
Autor:
Shore ND (AUTHOR)
Publikováno v:
Urology. May2011, Vol. 77 Issue 5, p1095-1096. 3p.
Autor:
Shore ND (AUTHOR), Shore, Neal D (AUTHOR)
Publikováno v:
Urology. Nov2010, Vol. 76 Issue 5, p1167-1168. 2p.
Autor:
Marberger M (AUTHOR), Kaisary AV (AUTHOR), Shore ND (AUTHOR), Karlin GS (AUTHOR), Savulsky C (AUTHOR), Mis R (AUTHOR), Leuratti C (AUTHOR), Germa JR (AUTHOR)
Publikováno v:
Clinical Therapeutics. Apr2010, Vol. 32 Issue 4, p744-757. 14p.
Autor:
Neeraj Agarwal, Arun Azad, Neal D Shore, Joan Carles, Andre P Fay, Curtis Dunshee, Lawrence Ivan Karsh, Maria Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy, Xun Lin, Akos Czibere, Karim Fizazi
Publikováno v:
Scientia
PARP inhibitor; Androgen receptor; Enzalutamide Inhibidor de PARP; Receptor d'andrògens; Enzalutamida Inhibidor de PARP; Receptor de andrógenos; Enzalutamida PARP inhibitors in combination with androgen receptor-targeted therapy have demonstrated p